IRD: the cash flow

MyFinsight

For the year ending 2025-12-31, IRD had $14,770K increase in cash & cash equivalents over the period.

Cash Flow	2025-12-31
Net loss	-49,591
Stock-based compensation	3,399
Depreciation	53
Fair value change in warrant and other derivative liabilities	-11,515
Warrant financing costs	1,337
Non-cash interest	129
Non-cash share issuances	57
Unrealized loss from short-term investments	-2
Acquired in-process research and development	0
Gain in connection with asset acquisition	0
Accounts receivable	-1,568
Contract assets and unbilled receivables	-1,039
Prepaid expenses and other assets	1,273
Accounts payable	7
Accrued expenses and other liabilities	-3,495
Net cash used in operating activities	-35,253
Cash received in connection with asset acquisition	0
Net cash provided by investing activities	0
Proceeds from issuance of common stock and pre-funded warrants in connection with the registered direct offering	22,999
Proceeds from issuance of common stock and pre-funded warrants in connection with the march 2025 offering and march 2025 private placement	5,980
Proceeds from issuance of warrants in connection with the march 2025 offering and march 2025 private placement	15,520
Proceeds from issuance of common stock	5,805
Issuance costs attributed to equity instruments	2,301
Proceeds from funding agreement, related party	1,000
Share repurchases for the payment of employee taxes	152
Exercise of warrants	820
Exercise of stock options	352
Net cash provided by financing activities	50,023
Net increase (decrease) in cash and cash equivalents	14,770
Cash and cash equivalents at beginning of period	30,321
Cash and cash equivalents at end of period	45,091

Unit: Thousand (K) dollars (except for numbers of shares and EPS).